Literature DB >> 54743

Non-specific cytotoxicity of wheat gliadin components towards cultured human cells.

D A Hudson, H J Cornell, D R Purdham, C J Rolles.   

Abstract

Chromatographically separated fractions of a proteolytic digest of wheat gliadin were assayed for cytotoxic properties using cultured human embryonic intestinal, lung, kidney, adrenal, and HEp-2 cells. In all cell types noxious effects were observed microscopically over a 24 h period. The most active fraction was that previously shown to produce xylose malabsorption in subjects with coeliac disease, disruption of lysosomes, and inhibition of morphological recovery of cultured mucosa from a patient on a gluten-free diet.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 54743     DOI: 10.1016/s0140-6736(76)90089-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  9 in total

1.  Coeliac disease: A review of the causative agents and their possible mechanisms of action.

Authors:  H J Cornell
Journal:  Amino Acids       Date:  1996-03       Impact factor: 3.520

2.  Activation of the alternative pathway by gluten. A possible aetiological factor in dermatitis herpetiformis.

Authors:  A Massey; P M Capner; J F Mowbray
Journal:  Immunology       Date:  1977-09       Impact factor: 7.397

3.  Damaging effects of gliadin on three-dimensional cell culture model.

Authors:  Ersilia Dolfini; Luca Elli; Leda Roncoroni; Barbara Costa; Maria-Pia Colleoni; Vito Lorusso; Simona Ramponi; Paola Braidotti; Stefano Ferrero; Maria-Letizia Falini; Maria-Teresa Bardella
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

4.  Nodular prurigo assiciated with gluten enteropathy.

Authors:  P G Goodwin
Journal:  Proc R Soc Med       Date:  1977-02

5.  A role for tissue transglutaminase in alpha-gliadin peptide cytotoxicity.

Authors:  W Sakly; V Thomas; G Quash; S El Alaoui
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

6.  Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients.

Authors:  D Bernardo; J A Garrote; Y Allegretti; A León; E Gómez; J F Bermejo-Martin; C Calvo; S Riestra; L Fernández-Salazar; A Blanco-Quirós; F Chirdo; E Arranz
Journal:  Clin Exp Immunol       Date:  2008-10       Impact factor: 4.330

7.  Re-evaluation of the techique of organ culture for studying gluten toxicity in coeliac disease.

Authors:  H P Hauri; M Kedinger; K Haffen; H Gaze; B Hadorn; W Hekkens
Journal:  Gut       Date:  1978-12       Impact factor: 23.059

8.  Further evidence of a primary mucosal defect in coeliac disease.

Authors:  H J Cornell; C J Rolles
Journal:  Gut       Date:  1978-04       Impact factor: 23.059

9.  The activities of alanine aminopeptidase, leucine aminopeptidase, proline dipeptidase and prolyl dipeptidase in the mucosa of the small intestine. Investigations on normal children and patients with the malabsorption syndrome.

Authors:  J Grävinghoff; H J Hütter
Journal:  Eur J Pediatr       Date:  1977-12-30       Impact factor: 3.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.